These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7621881)

  • 21. Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance.
    Clodi K; Asgari Z; Younes M; Palmer JL; Cabanillas F; Carbone A; Andreeff M; Younes A
    Cancer; 2002 Jan; 94(1):1-5. PubMed ID: 11815953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of B cell costimulatory function by recombinant murine CD40 ligand.
    Kennedy MK; Mohler KM; Shanebeck KD; Baum PR; Picha KS; Otten-Evans CA; Janeway CA; Grabstein KH
    Eur J Immunol; 1994 Jan; 24(1):116-23. PubMed ID: 7517359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD30: expression and function in health and disease.
    Horie R; Watanabe T
    Semin Immunol; 1998 Dec; 10(6):457-70. PubMed ID: 9826579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line.
    Pinto A; Aldinucci D; Gloghini A; Zagonel V; Degan M; Improta S; Juzbasic S; Todesco M; Perin V; Gattei V; Herrmann F; Gruss HJ; Carbone A
    Blood; 1996 Nov; 88(9):3299-305. PubMed ID: 8896393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
    Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
    Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A family of ligands for the TNF receptor superfamily.
    Cosman D
    Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines.
    Armitage RJ; Macduff BM; Spriggs MK; Fanslow WC
    J Immunol; 1993 May; 150(9):3671-80. PubMed ID: 8097223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD30-ligand and CD40-ligand expression in lymph nodes involved with Hodgkin's disease.
    Younes A; Zhao S; Zhang X; Snell V; Clodi K; Kliche KO; Thomas E; Cabanillas F; Andreeff M
    Ann Oncol; 1997; 8 Suppl 2():97-100. PubMed ID: 9209650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.
    Watanabe M; Ogawa Y; Ito K; Higashihara M; Kadin ME; Abraham LJ; Watanabe T; Horie R
    Am J Pathol; 2003 Aug; 163(2):633-41. PubMed ID: 12875982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpesvirus saimiri-transformed human CD4+ T cells can provide polyclonal B cell help via the CD40 ligand as well as the TNF-alpha pathway and through release of lymphokines.
    Saha K; Ware R; Yellin MJ; Chess L; Lowy I
    J Immunol; 1996 Nov; 157(9):3876-85. PubMed ID: 8892618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of current and new discriminating markers in the immunodiagnosis of Hodgkin's disease and other phenotypically related lymphomas.
    Carbone A; Gloghini A
    Pathologica; 1996 Jun; 88(3):169-74. PubMed ID: 8916443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production.
    Liu Z; Colpaert S; D'Haens GR; Kasran A; de Boer M; Rutgeerts P; Geboes K; Ceuppens JL
    J Immunol; 1999 Oct; 163(7):4049-57. PubMed ID: 10491009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.
    Kashii Y; Giorda R; Herberman RB; Whiteside TL; Vujanovic NL
    J Immunol; 1999 Nov; 163(10):5358-66. PubMed ID: 10553060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxsackievirus B3.
    Seko Y; Takahashi N; Oshima H; Shimozato O; Akiba H; Takeda K; Kobata T; Yagita H; Okumura K; Azuma M; Nagai R
    J Pathol; 2001 Dec; 195(5):593-603. PubMed ID: 11745696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role and expression of CD40 on human retinal pigment epithelial cells.
    Willermain F; Caspers-Velu L; Baudson N; Dubois C; Hamdane M; Willems F; Velu T; Bruyns C
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3485-91. PubMed ID: 11006243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hodgkin's Disease and Anaplastic Large Cell Lymphoma Revisited. 1. unique cytokine and cytokine receptor profile distinguished from that of non-hodgkin's lymphomas.
    Hsu SM; Waldron J; Xie SS; Hsu PL
    J Biomed Sci; 1995 Oct; 2(4):302-313. PubMed ID: 11725067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
    Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
    Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.
    Molin D; Fischer M; Xiang Z; Larsson U; Harvima I; Venge P; Nilsson K; Sundström C; Enblad G; Nilsson G
    Br J Haematol; 2001 Sep; 114(3):616-23. PubMed ID: 11552987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transactivation of the ICAM-1 gene by CD30 in Hodgkin's lymphoma.
    Uchihara JN; Matsuda T; Okudaira T; Ishikawa C; Masuda M; Horie R; Watanabe T; Ohta T; Takasu N; Mori N
    Int J Cancer; 2006 Mar; 118(5):1098-107. PubMed ID: 16152613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD30 ligand in lymphoma patients with CD30+ tumors.
    Younes A; Consoli U; Snell V; Clodi K; Kliche KO; Palmer JL; Gruss HJ; Armitage R; Thomas EK; Cabanillas F; Andreeff M
    J Clin Oncol; 1997 Nov; 15(11):3355-62. PubMed ID: 9363866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.